OPL-0401

· Valo Health, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OPL-0401, covering 2024-06-17 to 2024-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy [Phase 2]

See pricing